Stocks in Focus: Tremor Video, Inc. (NYSE:TRMR), Loxo Oncology, Inc. (NASDAQ:LOXO), Ryanair Holdings plc (NASDAQ:RYAAY), Global Payments Inc. (NYSE:GPN), Anthera Pharmaceuticals (NASDAQ:ANTH)

Tremor Video, Inc. (NYSE:TRMR) belongs to Technology sector. Its net profit margin is -14.10% and weekly performance is 2.64%. On last trading day company shares ended up $2.72. Tremor Video, Inc. (NYSE:TRMR) distance from 50-day simple moving average (SMA50) is -2.63%. Tremor Video, Inc. (NYSE:TRMR), will announce its financial results for the second quarter ended June 30, 2015 on August 6, 2015 after the market close.

Loxo Oncology, Inc. (NASDAQ:LOXO) shares moved down -0.43% in last trading session and ended the day at $16.35. LOXO return on assets is -24.10%. Loxo Oncology, Inc. (NASDAQ:LOXO) quarterly performance is 28.74%. Loxo Oncology, Inc. (NASDAQ:LOXO), announced that Joshua H. Bilenker, M.D., chief executive officer, presented a corporate overview at the JMP Securities Life Sciences Conference in New York City on Wednesday, June 24, 2015 at 11:30AM Eastern Time.

On 10 July, Ryanair Holdings plc (NASDAQ:RYAAY) shares increased 2.09% and was closed at $73.25. RYAAY EPS growth in last 5 year was 24.90%. Ryanair Holdings plc (NASDAQ:RYAAY) year to date (YTD) performance is 6.32%. Ryanair Holdings Plc’s (NASDAQ:RYAAY) board voted to accept an offer from IAG SA for its 29.8 percent stake in Aer Lingus Group Plc, removing one of the last hurdles in the British Airways owner’s quest to add the Irish carrier to its portfolio.

Global Payments Inc. (NYSE:GPN) ended the last trading day at $105.95. Company weekly volatility is calculated as 1.67% and price to cash ratio as 11.54. Global Payments Inc. (NYSE:GPN) showed a weekly performance of 1.32%. Global Payments (NYSE:GPN)‘s stock had its “hold” rating reiterated by research analysts at Barclays in a report released on Thursday, MarketBeat reports. They currently have a $110.00 price objective on the stock, up from their previous price objective of $100.00. Barclays’ target price would indicate a potential upside of 5.25% from the company’s current price.

Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) shares advanced 11.45% in last trading session and ended the day at $8.32. ANTH return on assets is -133.60%. Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) quarterly performance is 96.81%. Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The Company expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering. The Company intends to use the net proceeds from the offering for clinical research and development and general corporate purposes.

Leave a Reply

Your email address will not be published. Required fields are marked *